je.st
news
Ironwood borrows $175M to fund IBS drug launch
2013-01-05 13:00:31| Biotech - Topix.net
Ironwood Pharmaceuticals , Inc. has completed a $175 million debt offering to support the launch of its newly approved drug for irritable bowel syndrome , Linzess.
Tags: drug
fund
launch
ibs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||